S.1: Experimental Procedure
Methods and materials. Tetrabutylammonium hexamolybdate [TBA]2[Mo6O19] was prepared by literature procedure. 1 All other reagents were purchased commercially and used without further purification. ESI mass spectra were acquired using a Bruker microTOF-Q III spectrometer interfaced to a Dionex UltiMate 3000 LC in negative mode. X-ray analyses were performed using a Bruker APEX2 Duo diffractometer equipped with a Mo-Kα source (λ = 0.71073 Å) and a Bruker SMART APEX2 area detector. Structures were solved using Bruker APEX v2011.8-0 software. Where appropriate, the SQUEEZE/PLATON routine was used to model disordered solvent molecules. Infrared data were obtained using a PerkinElmer Spectrum One FT-IR spectrometer with a universal Attenuated Total Reflectance (ATR) sampling accessory. Thermogravimetric analyses were performed using a Perkin Elmer Pyriss 1 TGA instrument under nitrogen at a rate of 10˚ C/min. MALDI-TOF spectra were acquired using a Waters Maldi Q-Tof Premier in negative mode using DCTB as a MALDI matrix.
Synthetic procedure.
[TBA]2[Mo6O19] (0.137 g, 0.1 mmol), copper (II) acetate monohydrate (0.100 g, 0.5 mmol), tert-butylphosphonic acid (0.067 g, 0.5 mmol) and tetrabutylammonium bromide (0.322 g, 1.0 mmol) were combined in methanol (25mL) and pyridine (80 µl, 1.0 mmol) was added. The system was refluxed for one hour before being stirred at room temperature for a further 4-5 hours. The solution was filtered and the filtrate was left to stand at room temperature for 1-2 weeks, during which time both 1 and 2 crystallise from solution. 1 and 2 can be separated manually: However the intensity of the signal is quite low, rendering the assignment ambiguous. . The signal intensity generally decreases on increasing CV, and indicating that this signal arises from a "real" solutionphase species. . The signal intensity is low, rendering the assignment ambiguous, but the signal quickly vanishes on increasing CV, indicating that the signal represents a "real" solution-phase species. . The signal intensity is very low and does not display a clear trend with respect to CV, rendering assignment ambiguous.
S.3: Crystal data (1 & 2)
Single crystal X-ray structure determination of the two compounds, were performed at 100(K) on the Bruker SMART Apex DUO diffractometer using graphite-monochromated Mo-K radiation (λ = 0.71073 Å). The data sets were processed and corrected for Lorentz and polarisation effects using SMART 1 and SAINT-PLUS 2 software. The structures were solved using direct methods with the SHELXTL 3 program package. Data integration, reduction and correction for absorption and polarisation effects were all performed using the Crystalclear-SM 1.4.0 software. 4 Space group determination; structure solution and refinement were obtained using the Crystal structure ver.3.8 and the Bruker SHELXTL 3 software. The structures were solved using Bruker APEX v2011.8-0 software. 5 All atoms except H atoms were refined anisotropically. Hydrogen atoms were assigned to calculated positions using a riding model with appropriately fixed isotropic thermal parameters. Crystal data and details of data collection and refinement of 1 and 2 are summarized in Tables S3.1-S3 .2. The SQUEEZE routine within the PLATON software package was applied for 2. Theta range for data collection 1.617 to 27.528°. Refinement Note: One Bu4N group was disordered and each arm was modelled in two locations with occupancies 67/33%. The last carbon atom on one chain of the other unique cation was modelled in two positions with occupancy 54:45%. Restraints (DFIX, EADP) were used to model the disorder in both cases. The MeOH solvent molecule C-O distances were restrained (DFIX) and the half occupied solvent molecule atoms were held isotropic. The hydrogen atoms associated with the solvent water molecule were not located. The formula includes these absent atoms. 
